Tag: Christine Gebski

Repligen Corporation, a life sciences company focused on bioprocessing technology, has recently declared the commercial launch of its single-use version of XCell™ ATF, a proprietary cell retention system used by biologic drug manufacturers to intensify cell culture and improve the efficiency and productivity of upstream processes.